Microscale 3D printing enables additive manufacturing at micrometer scale utilizing various processes including stereolithography, inkjet printing, direct laser writing, and microextrusion to print 3D objects with complex structures, geometries, and properties. The technology is finding wide applications in various industries including healthcare, aerospace, electronics, and automotive due to advantages like high resolution, complex geometries, lightweight parts. The global Microscale 3D Printing Market is estimated to be valued at US$ 23.79 Billion in 2024 and is expected to exhibit a CAGR of 8.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Miniaturization has been one of the key trends driving the growth of microscale 3D printing market. Miniaturization enables manufacturing of miniature objects, sensors, electronics and more which otherwise is not possible through conventional 3D printing methods. Advancements in microscale 3D printing technologies has enabled fabricating objects with micro-level details and complexity. This has increased adoption of microscale 3D printing across industries requiring miniature objects. Growing demand for miniaturized medical devices, microfluidics, MEMS, and miniaturized electronics from healthcare and electronics industries has fueled the miniaturization trend thereby accelerating growth of the microscale 3D printing market during the forecast period.
Segment Analysis
The microscale 3D printing market is dominated by the biomaterial sub segment which holds more than 30% share of the overall market. This is due to the increasing applications of microscale 3D printing technology in manufacturing medical implants, biosensors, organs on chips and developing microfluidic medical devices. The biomaterial sub segment is expected to witness higher growth during the forecast period owing to ongoing research and development for organ transplant and 3D bio-printing of tissues and organs.
Key Takeaways
The Global Microscale 3D Printing Market Size is expected to witness high growth during the forecast period between 2024 to 2031 driven by technological advancement in nanotechnology and microfabrication.
Regional analysis: North America currently dominates the microscale 3D printing market with over 40% share due to presence of major players, developed healthcare infrastructure and active government funding for nanotechnology research. Asia Pacific is expected to be the fastest growing region during the forecast period supported by growing geriatric population, rising medical tourism and investment by governments to strengthen healthcare facilities. China, India and Japan are likely to drive the demand for microscale 3D printing technology in Asia Pacific region.
Key players operating in the Microscale 3D Printing market are Beckman Coulter, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Bioporto Diagnostics A/S, Astute Medical, Inc., Randox Laboratories, Sphingo Tec GmbH, Siemens Healthineers AG, Eli Lilly and Company, and Novartis AG. Beckman Coulter, Inc. and Thermo Fisher Scientific Inc. together account for over 20% share of the overall market.
Explore more information on this topic, Please visit-
https://www.insightprobing.com/microscale-3d-printing-market-growth-and-trnds-analysis-share-size-demand-forecast/
Explore more trending article on this topic:
https://masstamilan.tv/printed-electronics-the-future-of-electronics-manufacturing/
Comments
0 comment